Glycopeptides Are No More Effective than -Lactam Agents for Prevention of Surgical Site Infection after Cardiac Surgery: A Meta-analysis
Open Access
- 15 May 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (10) , 1357-1363
- https://doi.org/10.1086/383318
Abstract
A meta-analysis was performed to investigate whether a switch from β-lactams to glycopeptides for cardiac surgery prophylaxis should be advised. ResuKeywords
This publication has 43 references indexed in Scilit:
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002American Journal of Infection Control, 2002
- Nonrandom Selection and The Attributable Cost of Surgical-Site InfectionsInfection Control & Hospital Epidemiology, 2002
- Cost of surgical site infections following coronary artery bypass surgeryAnz Journal of Surgery, 2001
- Quantifying Excess Length of Postoperative Stay Attributable to Infections: A Comparison of MethodsJournal of Clinical Epidemiology, 1999
- Mediastinitis After Coronary Artery Bypass Graft SurgeryCirculation, 1995
- Antibiotic prophylaxis for cardiothoracic operationsThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Wound Infection Rates in Clean Surgery: A Potentially Misleading Risk ClassificationInfection Control & Hospital Epidemiology, 1992
- Added Hospital Stay Due to Wound Infections Following Cardiac SurgeryThe Thoracic and Cardiovascular Surgeon, 1992
- The value of prophylactic antibiotics in aorta-coronary bypass operationsThe Journal of Thoracic and Cardiovascular Surgery, 1979
- Infection after Cardiovascular SurgeryNew England Journal of Medicine, 1968